(MedPage Today) — Men with early prostate cancer had significantly less disease progression when treated with dutasteride (Avodart) as part of active surveillance, results of a randomized trial showed.
-
-
Recent Posts
Archives
Categories
-
(MedPage Today) — Men with early prostate cancer had significantly less disease progression when treated with dutasteride (Avodart) as part of active surveillance, results of a randomized trial showed.